Thienopyrimidine Derivatives Specifically Activate Testicular Steroidogenesis but Do Not Affect Thyroid Functions

[1]  A. Shpakov,et al.  Specificity of heterotrimeric G protein regulation by human chorionic gonadotropin and low-molecular agonist of luteinizing hormone receptor , 2017, Cell and Tissue Biology.

[2]  Catherine L. Worth,et al.  Structural–Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work , 2017, Front. Endocrinol..

[3]  R. Yvinec,et al.  Human Luteinizing Hormone and Chorionic Gonadotropin Display Biased Agonism at the LH and LH/CG Receptors , 2017, Scientific Reports.

[4]  A. Shpakov,et al.  The stimulating effect of thienopyrimidines structurally similar to Org 43553 on adenylate cyclase activity in the testes and on testosterone production in male rats , 2017, Cell and Tissue Biology.

[5]  A. Shpakov,et al.  In vitro and in vivo studies of functional activity of new low molecular weight agonists of the luteinizing hormone receptor , 2016, Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology.

[6]  M. Simoni,et al.  β-arrestins regulate gonadotropin receptor-mediated cell proliferation and apoptosis by controlling different FSHR or LHCGR intracellular signaling in the hGL5 cell line , 2016, Molecular and Cellular Endocrinology.

[7]  M. Mezei,et al.  TSH Receptor Signaling Abrogation by a Novel Small Molecule , 2016, Front. Endocrinol..

[8]  R. Place,et al.  An Enantiomer of an Oral Small-Molecule TSH Receptor Agonist Exhibits Improved Pharmacologic Properties , 2016, Front. Endocrinol..

[9]  T. Fournier.  Human chorionic gonadotropin: Different glycoforms and biological activity depending on its source of production. , 2016, Annales d'endocrinologie.

[10]  G. Morgia,et al.  Late-onset hypogonadism: the advantages of treatment with human chorionic gonadotropin rather than testosterone , 2016, The aging male : the official journal of the International Society for the Study of the Aging Male.

[11]  A. Shpakov,et al.  The Influence of Intranasal Insulin on Hypothalamic-Pituitary-Thyroid Axis in Normal and Diabetic Rats , 2015, Hormone and Metabolic Research.

[12]  A. Shpakov,et al.  Intranasal and Intramuscular Administration of Lysine-Palmitoylated Peptide 612–627 of Thyroid-Stimulating Hormone Receptor Increases the Level of Thyroid Hormones in Rats , 2015, International Journal of Peptide Research and Therapeutics.

[13]  A. Shpakov,et al.  Peptide 612–627 of thyrotropin receptor and its modified analogs as regulators of adenylyl cyclase in rat thyroid gland , 2014, Cell and Tissue Biology.

[14]  A. Shpakov,et al.  Intratesticular, intraperitoneal, and oral administration of thienopyrimidine derivatives increases the testosterone level in male rats , 2014, Doklady Biological Sciences.

[15]  A. Shpakov,et al.  Activation of adenylyl cyclase by thienopyrimidine derivatives in rat testes and ovaries , 2014, Cell and Tissue Biology.

[16]  A. Shpakov,et al.  The stimulating influence of thienopyrimidine compounds on the adenylyl cyclase signaling systems in the rat testes , 2014, Doklady Biochemistry and Biophysics.

[17]  R. Hanssen,et al.  First evidence of ovulation induced by oral LH agonists in healthy female volunteers of reproductive age. , 2013, The Journal of clinical endocrinology and metabolism.

[18]  G. Krause,et al.  G-protein-coupled Receptors: from Structural Insights to Functional Mechanisms Molecular Sampling of the Allosteric Binding Pocket of the Tsh Receptor Provides Discriminative Pharmacophores for Antagonist and Agonists , 2022 .

[19]  L. Cole.  hCG, the wonder of today's science , 2012, Reproductive Biology and Endocrinology.

[20]  C. McArdle,et al.  Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonist , 2011, Proceedings of the National Academy of Sciences.

[21]  M. Gershengorn,et al.  Small molecule TSHR agonists and antagonists. , 2011, Annales d'endocrinologie.

[22]  A. Shpakov,et al.  The Peptides Mimicking the Third Intracellular Loop of 5-Hydroxytryptamine Receptors of the Types 1B and 6 Selectively Activate G Proteins and Receptor-Specifically Inhibit Serotonin Signaling via the Adenylyl Cyclase System , 2010, International Journal of Peptide Research and Therapeutics.

[23]  C. Timmers,et al.  Induction of ovulation by a potent, orally active, low molecular weight agonist (Org 43553) of the luteinizing hormone receptor. , 2008, Human reproduction.

[24]  B. Raaka,et al.  A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism. , 2008, Endocrinology.

[25]  Gerd Krause,et al.  Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: structure-activity relationships and selective binding patterns. , 2006, Journal of medicinal chemistry.

[26]  C. Timmers,et al.  The First Orally Active Low Molecular Weight Agonists for the LH Receptor: Thienopyr(im)idines with Therapeutic Potential for Ovulation Induction , 2002, Chembiochem : a European journal of chemical biology.

[27]  Shpakov Ao.  [New achievements in the development and study of the mechanisms of action of the low molecular weight agonists of receptors of the thyroid-stimulating and the luteinizing hormones]. , 2015 .